Orient EuroPharma Co., Ltd. (TPEX:4120)

Market Cap	3.87B -3.0%
Revenue (ttm)	4.59B +3.3%
Net Income	-438.65M
EPS	-5.07
Shares Out	86.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	4.00 (8.97%)
Ex-Dividend Date	n/a

Volume	41,383
Open	44.40
Previous Close	44.35
Day's Range	44.40 - 44.60
52-Week Range	42.60 - 58.90
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	May 26, 2026

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include weight management, andrology, cardiovascular, respiratory, neurology, cardiovascular, metabolism, obstetrics and gynecology, antibiotic, immunology, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplements for liquid nutrition, regular blood lipids, L-arginines, agile movements, and improved sleep qualities under the N...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 339
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4120

Financial Performance

In 2025, Orient EuroPharma's revenue was 4.60 billion, an increase of 4.64% compared to the previous year's 4.39 billion. Losses were -567.39 million, 99.8% more than in 2024.